Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.330
+0.020 (0.87%)
At close: Aug 7, 2026, 4:00 PM EDT
2.340
+0.010 (0.43%)
After-hours: Aug 7, 2026, 7:39 PM EDT
Veru Inc. Employees
Veru Inc. had 20 employees as of September 30, 2025. The number of employees decreased by 190 or -90.48% compared to the previous year.
Employees
20
Change (1Y)
-190
Growth (1Y)
-90.48%
Revenue / Employee
n/a
Profits / Employee
-$697,651
Market Cap
37.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 20 | -190 | -90.48% | 20 | 0 |
| Sep 30, 2024 | 210 | 21 | 11.11% | 210 | 0 |
| Sep 30, 2023 | 189 | -44 | -18.88% | 189 | 0 |
| Sep 30, 2022 | 233 | -19 | -7.54% | 233 | 0 |
| Sep 30, 2021 | 252 | -87 | -25.66% | 252 | 0 |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| BeyondSpring | 44 |
| Enlivex | 34 |
| Lantern Pharma | 16 |
| Serina Therapeutics | 16 |
| CervoMed | 15 |
| Apollomics | 14 |
| Nutriband | 13 |
VERU News
- 5 days ago - Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss - GlobeNewsWire
- 6 days ago - Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th - GlobeNewsWire
- 10 days ago - Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference - GlobeNewsWire
- 13 days ago - Veru completes enrollment in PLATEAU clinical study - TheFly
- 13 days ago - Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss - GlobeNewsWire
- 4 weeks ago - Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day - GlobeNewsWire
- 2 months ago - Veru pact with Novo ‘significant event,’ says Canaccord - TheFly
- 2 months ago - Veru announces clinical supply agreement with Novo Nordisk - TheFly